Publications by authors named "Hartmut Lode"

Claim this Profile
C
Community-acquired pneumonia - An EFIM guideline critical appraisal adaptation for internists.
Ahmet Gorkem Er, Alberto Antonio Romero Alonso, Ignacio Marin-Leon, Abdullah Sayiner, Stefano Bassetti, Hartmut Lode

Eur J Intern Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Bacterial Toxins in the Lungs.
Rudolf Lucas, Yalda Hadizamani, Joyce Gonzales, Boris Gorshkov, Thomas Bodmer, Hartmut Lode

Toxins (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication for COVID-19-an Overview of Approaches Currently Under Study.
Ralf Stahlmann, Hartmut Lode

Dtsch Arztebl Int· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calculated parenteral initial treatment of bacterial infections: Respiratory infections.
Sebastian R Ott, Klaus-Friedrich Bodmann, Béatrice Grabein, Gert Höffken, Martin Kolditz, Hartmut Lode

GMS Infect Dis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty.
Ralf Stahlmann, Hartmut Lode

GMS Infect Dis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical positioning of telavancin in Europe.
Robert Masterton, Giuseppe Cornaglia, Patrice Courvalin, Hartmut M Lode, Jordi Rello

Int J Antimicrob Agents· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacokinetics of antibiotics in obese and critical care patients].
Ralf Stahlmann, Hartmut Lode

Dtsch Med Wochenschr· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preserving the efficacy of front-line fluoroquinolones through selective use to optimise clinical outcomes.
Hartmut M Lode

Int J Antimicrob Agents· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adults.
Endre Ludwig, Serhat Unal, Miron Bogdan, Roman Chlíbek, Yavor Ivanov, Hartmut Lode

Cent Eur J Public Health· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks associated with the therapeutic use of fluoroquinolones.
Ralf Stahlmann, Hartmut M Lode

Expert Opin Drug Saf· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal infection--low awareness as a potential barrier to vaccination: results of a European study.
Hartmut Lode, Endre Ludwig, George Kassianos

Adv Ther· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunity for healthy ageing: lessening the burden of adult pneumococcal disease in Central and Eastern Europe, and Israel.
Endre Ludwig, Serhat Unal, Miron Bogdan, Roman Chlibek, Yavor Ivanov, Hartmut Lode

Cent Eur J Public Health· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza.
Mark L Metersky, Robert G Masterton, Hartmut Lode, Thomas M File, Timothy Babinchak

Int J Infect Dis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A European care bundle for prevention of ventilator-associated pneumonia.
Jordi Rello, Hartmut Lode, Giuseppe Cornaglia, Robert Masterton,

Intensive Care Med· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effects of dexamethasone and quinolones on human-derived tendon cells.
Judith Sendzik, Mehdi Shakibaei, Monika Schäfer-Korting, Hartmut Lode, Ralf Stahlmann

Int J Antimicrob Agents· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections.
Hartmut Lode

Am J Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety considerations of fluoroquinolones in the elderly: an update.
Ralf Stahlmann, Hartmut Lode

Drugs Aging· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
Judith Sendzik, Hartmut Lode, Ralf Stahlmann

Int J Antimicrob Agents· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
Mathias W Pletz, Ulrich Maus, Norbert Krug, Tobias Welte, Hartmut Lode

Int J Antimicrob Agents· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin: update and perspectives after 8 years of usage.
Hartmut M Lode, Malina Schmidt-Ioanas

Expert Rev Respir Med· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational antibiotic therapy and the position of ampicillin/sulbactam.
Hartmut M Lode

Int J Antimicrob Agents· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Antoni Torres, Javier Garau, Pierre Arvis, Jean Carlet, Shurjeel Choudhri, Hartmut Lode

Clin Infect Dis· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemifloxacin for community-acquired pneumonia.
Hartmut M Lode, Malina Schmidt-Ionas, Ralf Stahlmann

Expert Opin Investig Drugs· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing community-acquired pneumonia: a European perspective.
Hartmut M Lode

Respir Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impersonator.
Hartmut Lode, Jutta Wagner, Hans Scherübl

Am J Med· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis